FOXM1 and head and neck carcinoma: Recently, FoxM1 silencing in head and neck carcinoma cells was found to augment cell cycle arrest induced by an Artemisinin derivative (47), hinting towards the prospective involvement of FoxM1 in the anticancer activities of Artemisinin.